Geneva, June 22 -- International Clinical Trials Registry received information related to the study (ChiCTR2600126558) titled 'A Multicenter, Randomized, Open-label Phase II Clinical Study to Evaluate the Efficacy and Safety of CG001 Injection in Participants with Paroxysmal Nocturnal Hemoglobinuria' on June 11.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Peking Union Medical College Hospital

Condition: Paroxysmal Nocturnal Hemoglobinuria (PNH)

Recruitment Status: Not Recruiting

Phase: 2

Date of First Enrollment: 2026-06-15

Target Sample Size: Test group:30;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=326089

Disclaimer: Curated by HT Syndica...